跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GRALISE EXTENDED RELEASE TABLETS 300 MG - HSA Drug Approval Details
Approvals
/
HSA
/
GRALISE EXTENDED RELEASE TABLETS 300 MG
Approved
THERAPEUTIC
GRALISE EXTENDED RELEASE TABLETS 300 MG
Norwich Pharmaceuticals, Inc.
🇸🇬 Health Sciences Authority
Approval Date
Jan 16, 2025
Approval ID
4919567f44b62a7b
Company
Norwich Pharmaceuticals, Inc.
Type
Therapeutic
Approval Details
Approval Id
4919567f44b62a7b
Drug Name
GRALISE EXTENDED RELEASE TABLETS 300 MG
Product Name
GRALISE EXTENDED RELEASE TABLETS 300 MG
Approval Number
SIN17166P
Approval Date
2025-01-16
Registrant
LOTUS INTERNATIONAL PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
N02BF01
Pharma Manufacturer Name
LOTUS INTERNATIONAL PTE. LTD.
Company Detail Path
/organization/lotus-international-pte-ltd
Active Ingredients
Gabapentin
300.00 mg
Gabapentin
300.00 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 16, 2025
Approval ID
4919567f44b62a7b
Type
Therapeutic
Back to HSA Approvals